Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

DSpace Repository

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

Author: Middeke, J. M.; Herbst, R.; Parmentier, S.; Bug, G.; Haenel, M.; Stuhlers, G.; Schaefer-Eckart, K.; Roester, W.; Klein, S.; Bethge, W.; Bitz, U.; Buettner, B.; Knoth, H.; Alakel, N.; Schaich, M.; Morgner, A.; Kramer, M.; Sockel, K.; von Bonin, M.; Stoelzel, F.; Platzbecker, U.; Roellig, C.; Thiede, C.; Ehninger, G.; Bornhaeuser, M.; Schetelig, J.
Tübinger Autor(en):
Bethge, Wolfgang Andreas
Published in: Leukemia (2016), Bd. 30, H. 2, S. 261-267
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/leu.2015.226
ISSN: 1476-5551
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)